CD33 and breast neoplasm: Furthermore, we examined the expressions of CD33 and CD15 in 31 breast tumor samples by immunohistochemistry (IHC) and found staining scores of these two PMN-MDSC markers were much higher in CCL20high-expressing tumors than in CCL20low-expressing tumors (Fig. 1m).